The Food and Drug Administration (FDA) conducted an OTC drug review of Ethylhexyl Methoxycinnamate (also called Octyl Methoxycinnamate) and approved the use of this ingredient as an active ingredient in sunscreen products up to a concentration of 7.5%. When used as an active ingredient in an OTC sunscreen product, this ingredient will be listed on the label as Octinoxate. The Cosmetic Ingredient Review (CIR) has deferred evaluation of this ingredient because the safety has been assessed by FDA. This deferral of review is according to the provisions of the CIR Procedures.